National trends in thyroid disease and COVID-19 pandemic-related factors, 1998–2021: A nationwide representative study in South Korea
Year: 2024
Type: article
Study design: Observational Study
Abstract: Objective: Although thyroid disease is a common condition, there is limited research examining the prevalence of thyroid disease over a long period of time, including both before and during the COVID-19 pandemic. Therefore, we aimed to investigate sociodemographic aspects that might be associated with thyroid disease and how its prevalence has varied during the pandemic. Methods: We assessed the prevalence of thyroid disease among Korean adults by using data from the Korea National Health and Nutrition Examination Survey from 1998 to 2021. We evaluated weighted prevalence and β-coefficients with 95 % CI for factors such as age, sex, residential area, education level, household income, perceived stress level, weight change, occupation category, and body mass index groups. Results: : 0.52 [95 % CI, 0.37-0.68]). Conclusions: A nationwide representative study in South Korea revealed an increasing trend in the prevalence of thyroid disease over 24 years, particularly among the older population. Despite the minimal variation during the pandemic, our findings emphasize the need for targeted thyroid disease policies and further research, especially for specific subgroups such as the older population.
Source: Heliyon
Institutions: Kyung Hee University, Kyung Hee University Medical Center, Yonsei University, Harvard University, Massachusetts General Hospital, Aix-Marseille Université, Vali Asr University of Rafsanjan, Lorestan University, Assistance Publique Hôpitaux de Marseille, Centre d’Etudes et de Recherche sur les Services de Santé et la Qualité de Vie, Parc Sanitari Sant Joan de Déu, Anglia Ruskin University, Universidad de Murcia, University of Ioannina
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,100
OpenAlex ID: W4403416405
